Industry: Chemical & Material
Published Date: 2025-06-21
Pages: 78 Pages
Report ld: 4770475
Request Sample
Customized Report
Tuna Peptides (L-Anserine) Market Size(US$)

CAGR 2025-2031
5.4%
Market Size,2031
USD 16.2
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Tuna Peptides (L-Anserine) market size was US$ 11.4 million in 2024 and is forecast to a readjusted size of US$ 16.2 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Tuna Peptides (L-Anserine) market competitiveness, regional economic performance, and supply chain configurations.
Tuna Peptides (L-Anserine) is a highly active dipeptide (β-alanyl-L-histidine) extracted from the dark muscle tissue of deep-sea tuna (such as bluefin tuna and yellowfin tuna) through bio-enzymatic hydrolysis technology. Its core functions include lowering uric acid, anti-oxidation, anti-glycation and anti-fatigue.
The North America Tuna Peptides (L-Anserine) market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Tuna Peptides (L-Anserine) include Yaizu Suisankagaku Industry, Beyond Biopharma, Lankun, Rongcheng Lanrun Biological Technology, Natide (Yangjiang) Biotechnology, Guangdong Shinyee Marine Biology Engineering, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Tuna Peptides (L-Anserine) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Tuna Peptides (L-Anserine) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Content 4%-10% in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Health Products in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Tuna Peptides (L-Anserine) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Tuna Peptides (L-Anserine) Product Scope
1.2 Tuna Peptides (L-Anserine) by Type
1.2.1 Global Tuna Peptides (L-Anserine) Sales by Type (2020 & 2024 & 2031)
1.2.2 Content≥10%
1.2.3 Content 4%-10%
1.2.4 Content<4%
1.3 Tuna Peptides (L-Anserine) by Application
1.3.1 Global Tuna Peptides (L-Anserine) Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Food
1.3.3 Health Products
1.3.4 Personal Care
1.3.5 Other
1.4 Global Tuna Peptides (L-Anserine) Market Estimates and Forecasts (2020-2031)
1.4.1 Global Tuna Peptides (L-Anserine) Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Tuna Peptides (L-Anserine) Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Tuna Peptides (L-Anserine) Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Tuna Peptides (L-Anserine) Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Tuna Peptides (L-Anserine) Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Tuna Peptides (L-Anserine) Sales Market Share by Region (2020-2025)
2.2.2 Global Tuna Peptides (L-Anserine) Revenue Market Share by Region (2020-2025)
2.3 Global Tuna Peptides (L-Anserine) Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Tuna Peptides (L-Anserine) Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Tuna Peptides (L-Anserine) Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Tuna Peptides (L-Anserine) Market Size and Prospective (2020-2031)
2.4.2 Europe Tuna Peptides (L-Anserine) Market Size and Prospective (2020-2031)
2.4.3 China Tuna Peptides (L-Anserine) Market Size and Prospective (2020-2031)
2.4.4 Japan Tuna Peptides (L-Anserine) Market Size and Prospective (2020-2031)
2.4.5 India Tuna Peptides (L-Anserine) Market Size and Prospective (2020-2031)
2.4.6 Southeast Asia Tuna Peptides (L-Anserine) Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Tuna Peptides (L-Anserine) Historic Market Review by Type (2020-2025)
3.1.1 Global Tuna Peptides (L-Anserine) Sales by Type (2020-2025)
3.1.2 Global Tuna Peptides (L-Anserine) Revenue by Type (2020-2025)
3.1.3 Global Tuna Peptides (L-Anserine) Price by Type (2020-2025)
3.2 Global Tuna Peptides (L-Anserine) Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Tuna Peptides (L-Anserine) Sales Forecast by Type (2026-2031)
3.2.2 Global Tuna Peptides (L-Anserine) Revenue Forecast by Type (2026-2031)
3.2.3 Global Tuna Peptides (L-Anserine) Price Forecast by Type (2026-2031)
3.3 Different Types Tuna Peptides (L-Anserine) Representative Players
4 Global Market Size by Application
4.1 Global Tuna Peptides (L-Anserine) Historic Market Review by Application (2020-2025)
4.1.1 Global Tuna Peptides (L-Anserine) Sales by Application (2020-2025)
4.1.2 Global Tuna Peptides (L-Anserine) Revenue by Application (2020-2025)
4.1.3 Global Tuna Peptides (L-Anserine) Price by Application (2020-2025)
4.2 Global Tuna Peptides (L-Anserine) Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Tuna Peptides (L-Anserine) Sales Forecast by Application (2026-2031)
4.2.2 Global Tuna Peptides (L-Anserine) Revenue Forecast by Application (2026-2031)
4.2.3 Global Tuna Peptides (L-Anserine) Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Tuna Peptides (L-Anserine) Application
5 Competition Landscape by Players
5.1 Global Tuna Peptides (L-Anserine) Sales by Players (2020-2025)
5.2 Global Top Tuna Peptides (L-Anserine) Players by Revenue (2020-2025)
5.3 Global Tuna Peptides (L-Anserine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuna Peptides (L-Anserine) as of 2024)
5.4 Global Tuna Peptides (L-Anserine) Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Tuna Peptides (L-Anserine), Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Tuna Peptides (L-Anserine), Product Type & Application
5.7 Global Key Manufacturers of Tuna Peptides (L-Anserine), Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Tuna Peptides (L-Anserine) Sales by Company
6.1.1.1 North America Tuna Peptides (L-Anserine) Sales by Company (2020-2025)
6.1.1.2 North America Tuna Peptides (L-Anserine) Revenue by Company (2020-2025)
6.1.2 North America Tuna Peptides (L-Anserine) Sales Breakdown by Type (2020-2025)
6.1.3 North America Tuna Peptides (L-Anserine) Sales Breakdown by Application (2020-2025)
6.1.4 North America Tuna Peptides (L-Anserine) Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Tuna Peptides (L-Anserine) Sales by Company
6.2.1.1 Europe Tuna Peptides (L-Anserine) Sales by Company (2020-2025)
6.2.1.2 Europe Tuna Peptides (L-Anserine) Revenue by Company (2020-2025)
6.2.2 Europe Tuna Peptides (L-Anserine) Sales Breakdown by Type (2020-2025)
6.2.3 Europe Tuna Peptides (L-Anserine) Sales Breakdown by Application (2020-2025)
6.2.4 Europe Tuna Peptides (L-Anserine) Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Tuna Peptides (L-Anserine) Sales by Company
6.3.1.1 China Tuna Peptides (L-Anserine) Sales by Company (2020-2025)
6.3.1.2 China Tuna Peptides (L-Anserine) Revenue by Company (2020-2025)
6.3.2 China Tuna Peptides (L-Anserine) Sales Breakdown by Type (2020-2025)
6.3.3 China Tuna Peptides (L-Anserine) Sales Breakdown by Application (2020-2025)
6.3.4 China Tuna Peptides (L-Anserine) Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Tuna Peptides (L-Anserine) Sales by Company
6.4.1.1 Japan Tuna Peptides (L-Anserine) Sales by Company (2020-2025)
6.4.1.2 Japan Tuna Peptides (L-Anserine) Revenue by Company (2020-2025)
6.4.2 Japan Tuna Peptides (L-Anserine) Sales Breakdown by Type (2020-2025)
6.4.3 Japan Tuna Peptides (L-Anserine) Sales Breakdown by Application (2020-2025)
6.4.4 Japan Tuna Peptides (L-Anserine) Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Tuna Peptides (L-Anserine) Sales by Company
6.5.1.1 India Tuna Peptides (L-Anserine) Sales by Company (2020-2025)
6.5.1.2 India Tuna Peptides (L-Anserine) Revenue by Company (2020-2025)
6.5.2 India Tuna Peptides (L-Anserine) Sales Breakdown by Type (2020-2025)
6.5.3 India Tuna Peptides (L-Anserine) Sales Breakdown by Application (2020-2025)
6.5.4 India Tuna Peptides (L-Anserine) Major Customer
6.5.5 India Market Trend and Opportunities
6.6 Southeast Asia Market: Players, Segments, Downstream and Major Customers
6.6.1 Southeast Asia Tuna Peptides (L-Anserine) Sales by Company
6.6.1.1 Southeast Asia Tuna Peptides (L-Anserine) Sales by Company (2020-2025)
6.6.1.2 Southeast Asia Tuna Peptides (L-Anserine) Revenue by Company (2020-2025)
6.6.2 Southeast Asia Tuna Peptides (L-Anserine) Sales Breakdown by Type (2020-2025)
6.6.3 Southeast Asia Tuna Peptides (L-Anserine) Sales Breakdown by Application (2020-2025)
6.6.4 Southeast Asia Tuna Peptides (L-Anserine) Major Customer
6.6.5 Southeast Asia Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Yaizu Suisankagaku Industry
7.1.1 Yaizu Suisankagaku Industry Company Information
7.1.2 Yaizu Suisankagaku Industry Business Overview
7.1.3 Yaizu Suisankagaku Industry Tuna Peptides (L-Anserine) Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Yaizu Suisankagaku Industry Tuna Peptides (L-Anserine) Products Offered
7.1.5 Yaizu Suisankagaku Industry Recent Development
7.2 Beyond Biopharma
7.2.1 Beyond Biopharma Company Information
7.2.2 Beyond Biopharma Business Overview
7.2.3 Beyond Biopharma Tuna Peptides (L-Anserine) Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Beyond Biopharma Tuna Peptides (L-Anserine) Products Offered
7.2.5 Beyond Biopharma Recent Development
7.3 Lankun
7.3.1 Lankun Company Information
7.3.2 Lankun Business Overview
7.3.3 Lankun Tuna Peptides (L-Anserine) Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Lankun Tuna Peptides (L-Anserine) Products Offered
7.3.5 Lankun Recent Development
7.4 Rongcheng Lanrun Biological Technology
7.4.1 Rongcheng Lanrun Biological Technology Company Information
7.4.2 Rongcheng Lanrun Biological Technology Business Overview
7.4.3 Rongcheng Lanrun Biological Technology Tuna Peptides (L-Anserine) Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Rongcheng Lanrun Biological Technology Tuna Peptides (L-Anserine) Products Offered
7.4.5 Rongcheng Lanrun Biological Technology Recent Development
7.5 Natide (Yangjiang) Biotechnology
7.5.1 Natide (Yangjiang) Biotechnology Company Information
7.5.2 Natide (Yangjiang) Biotechnology Business Overview
7.5.3 Natide (Yangjiang) Biotechnology Tuna Peptides (L-Anserine) Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Natide (Yangjiang) Biotechnology Tuna Peptides (L-Anserine) Products Offered
7.5.5 Natide (Yangjiang) Biotechnology Recent Development
7.6 Guangdong Shinyee Marine Biology Engineering
7.6.1 Guangdong Shinyee Marine Biology Engineering Company Information
7.6.2 Guangdong Shinyee Marine Biology Engineering Business Overview
7.6.3 Guangdong Shinyee Marine Biology Engineering Tuna Peptides (L-Anserine) Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Guangdong Shinyee Marine Biology Engineering Tuna Peptides (L-Anserine) Products Offered
7.6.5 Guangdong Shinyee Marine Biology Engineering Recent Development
8 Tuna Peptides (L-Anserine) Manufacturing Cost Analysis
8.1 Tuna Peptides (L-Anserine) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Tuna Peptides (L-Anserine)
8.4 Tuna Peptides (L-Anserine) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Tuna Peptides (L-Anserine) Distributors List
9.3 Tuna Peptides (L-Anserine) Customers
10 Tuna Peptides (L-Anserine) Market Dynamics
10.1 Tuna Peptides (L-Anserine) Industry Trends
10.2 Tuna Peptides (L-Anserine) Market Drivers
10.3 Tuna Peptides (L-Anserine) Market Challenges
10.4 Tuna Peptides (L-Anserine) Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Tuna Peptides (L-Anserine) market is projected to grow from US$ 11.82 million in 2025 to US$ 16.99 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-12
Pages: 144
USD 4900.00
(Single User License)
The global Tuna Peptides (L-Anserine) market size was US$ 11.82 million in 2025 and is forecast to reach a readjusted size of US$ 16.99 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 77
USD 4250.00
(Single User License)
The global Tuna Peptides (L-Anserine) market was valued at US$ 11.82 million in 2025 and is anticipated to reach US$ 16.99 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 130
USD 2900.00
(Single User License)
The global market for Tuna Peptides (L-Anserine) was estimated to be worth US$ 11.82 million in 2025 and is projected to reach US$ 16.99 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 108
USD 3950.00
(Single User License)
The global market for Tuna Peptides (L-Anserine) was valued at US$ 11.4 million in the year 2024 and is projected to reach a revised size of US$ 16.2 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-06-21
Pages: 90
USD 2900.00
(Single User License)
The global market for Tuna Peptides (L-Anserine) was estimated to be worth US$ 11.4 million in 2024 and is forecast to a readjusted size of US$ 16.2 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-06-21
Pages: 110
USD 3950.00
(Single User License)
The global Tuna Peptides (L-Anserine) market is projected to grow from US$ 11.8 million in 2025 to US$ 16.2 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period.
Published Date: 2025-06-21
Pages: 146
USD 4900.00
(Single User License)
The global Tuna Peptides (L-Anserine) market is projected to grow from US$ 11.82 million in 2025 to US$ 16.99 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 144
The global Tuna Peptides (L-Anserine) market size was US$ 11.82 million in 2025 and is forecast to reach a readjusted size of US$ 16.99 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 77
The global Tuna Peptides (L-Anserine) market was valued at US$ 11.82 million in 2025 and is anticipated to reach US$ 16.99 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-03-12
Pages: 130
The global market for Tuna Peptides (L-Anserine) was estimated to be worth US$ 11.82 million in 2025 and is projected to reach US$ 16.99 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-03-09
Pages: 108
The global market for Tuna Peptides (L-Anserine) was valued at US$ 11.4 million in the year 2024 and is projected to reach a revised size of US$ 16.2 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-06-21
Pages: 90
The global market for Tuna Peptides (L-Anserine) was estimated to be worth US$ 11.4 million in 2024 and is forecast to a readjusted size of US$ 16.2 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-06-21
Pages: 110
The global Tuna Peptides (L-Anserine) market is projected to grow from US$ 11.8 million in 2025 to US$ 16.2 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period.
Published: 2025-06-21
Pages: 146
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now